Cost-effectiveness Analysis of Levofloxacin and Sparfloxacin in the Treatment of Nongonococcus Urethritis(Cervicitis) Patients
- VernacularTitle:左氟沙星与司帕沙星口服治疗非淋菌性尿道(宫颈)炎的成本-效果分析
- Author:
Jun YAN
- Publication Type:Journal Article
- Keywords:
levofloxacin;
sparfloxacin;
nongonococcus(cervicitis)urethritis;
cost-effectiveness analysis
- From:
China Pharmacy
1991;0(02):-
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To evaluate the cost-effectiveness of levofloxacin and sparfloxacin in the treatment of non?gonococcus urethritis(cervicitis)patients.METHODS:The clinical data of levofloxacin and sparfloxacin in the treatment of nongonococcus urethritis were collected with evidence-based medicine method and were evaluated with pharmacoeconomic cost-effectiveness analysis.RESULTS:The cure rates of two drugs were71.16%(62.00%,80.32%),81.69%(78.71%,85.21%)and cost-effectiveness ratios were2.29and2.71respectively.The?C/?E was5.57.CONCLUSION:The cost-ef?fectiveness ratio of levofloxacin was lower than that of sparfloxacin although the cure rate of sparfloxacin for nongonococcus urethritis was better.
